ZEARL POUR-ON
  • Doramectin
  • Valid
Authorised in these countries:
  • Belgium
Export to PDF

Product identification

Medicine name:
ZEARL POUR-ON
Dectomax Pour-On 5 mg/ml Pour-on oplossing
Dectomax 5 mg/ml Solution pour pour-on
Dectomax 5 mg/ml Lösung zum übergiessen
Active substance and strength:
  • Doramectin
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA03
Authorisation number:
  • BE-V192202
Product identification number:
  • 47b058f0-2f6a-4bc7-8872-3b7e318d923f
Permanent identification number:
  • 600000027522

Product details

Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Pharmaceutical form:
  • Pour-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cattle

Availability

Package description:
  • Boîte de 1 flacon de 1 l
    Available in these countries:
    • Belgium
  • Boîte de 1 bidon de 2,5 l et de 1 adaptateur pour pistolet doseur
  • Boîte de 1 bidon de 5 l et de 1 adaptateur pour pistolet doseur
  • Boîte de 1 bidon de 3 l et de 1 adaptateur pour pistolet doseur
  • Boîte de 1 flacon de 250 ml
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Elanco France S.A.S.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • FR/V/0343/001
Date of authorisation status change:
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Authorisation country:
  • Belgium
Responsible authority:
  • FAMHP
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation issued:
Reference member state:
  • France
Concerned member states:
  • Belgium
  • Germany
  • United Kingdom (Northern Ireland)
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
Package Leaflet (PDF)
First published:
Last updated:
Package Leaflet (PDF)
First published:
Last updated:
Package Leaflet (PDF)
First published:
Last updated:
Summary of Product Characteristics (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."